Fingerprint
Dive into the research topics of 'Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Matthew Kearney, Lauren Franks, Shing Lee, Amy Tiersten, Della F. Makower, Tessa Cigler, Prabhjot Mundi, Dow Chung Chi, Anupama Goel, Pam Klein, Eleni Andreopoulou, Joseph Sparano, Meghna Trivedi, Melissa Accordino, Andrea Califano, Dawn L. Hershman, Jose Silva, Kevin Kalinsky
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations